Title of Invention

COSMETIC COMPOSITION

Abstract A cosmetic composition is provided which includes tapioca starch and ethylene brassylate in a cosmetically acceptable carrier. The composition provides a silky afterfeel to skin.
Full Text FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)


COSMETIC COMPOSITIONS WITH ETHYLENE BRASSYLATE
HINDUSTAN UNILEVER LIMITED, a company incorporated under
the Indian Companies Act, 1913 and having its registered office
at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India

The following specification particularly describes the invention and the manner in which it is to be performed


WO 2008/028900

PCT/EP2007/059220

COSMETIC COMPOSITIONS WITH ETHYLENE BRASSYLATE
5 BACKGROUND OF THE INVENTION
Field of the invention
The invention concerns cosmetic compositions with aesthetics providing a silky afterfeei
to the skin. 10
The Related Art
Proper aesthetics are essential to any successful skin cream or lotion. Without the proper
feel, consumers would not buy or use even those products with the most proven
dermatological benefits. 15
Silkiness is known to be imparted by a variety of silicone materials. Yet the silicones do
not transform compositions into a powdery afterfeei. Typical disclosures of silicone
materials for cosmetics are found in US 5 972 359 (Sine et al.) and US 6 524 598 B2
(Sunkel et al.) 20
Starches have been employed to enhance viscosity of liquid formulations. For instance,
US 5 824 323 (Fishman) reports skin lotion compositions with non-greasy skinfeel.
These formulas can contain a variety of starches including tapioca to provide body and
thickness to the lotions. 25
US 2006/0034876 A1 (Cheney et al.) reports on combinations of tapioca starch and
polyacrylic beads which deliver a silky rub-in aesthetic transforming into a powdery drier
skin afterfeei.
30 Although solutions have been suggested to solve the problem of delivering silky feel to the skin, there still remains the challenge of formulating a cosmetic that in a much greater variety of formulations can achieve the aesthetically required silky smooth skin afterfeei.

WO 2008/028900

PCT/EP2007/059220

SUMMARY OF THE INVENTION
A cosmetic composition is provided which includes:
(i) from 0.1 to 10% by weight of tapioca starch;
5 (ii) from 0.001 to 5% by weight of ethylene brassylate;
(iii) from 0.01 to 10% by weight of an emulsifier;
(iv) optionally, an effective amount to provide an initial silky feel upon skin contact of a
polysiloxane material;
(v) optionally, from 0.1 to 40% by weight of polyhydric alcohol;
10 (vi) optionally, an effective amount to preserve of a preservative; and
(vii) a cosmetically acceptable carrier.
DETAILED DESCRIPTION OF THE INVENTION
15
Now there is provided a cosmetic composition of exceptionally pleasant aesthetics. The composition delivers a silky afterfeel to skin. The afterfeel aesthetics are achieved with a combination of tapioca starch and ethylene brassylate.
20 Tapioca starch is a first component of the present invention. Tapioca, also known as Cassava or Manioc, is a root or tuber extract. The plant is a perennial that grows eight to twelve feet high and the roots can be as much as three feet long and five to ten inches in diameter. Cells of the tuber carry the tapioca starch. This starch is recovered by wet grinding the washed roots and continuous re-washing, resulting in a pure carbohydrate.
25 Particularly preferred is a powder source with a median particle size ranging from 1 to 100 micron (1000 nm to 100,000 nm), preferably from 5 to 15 micron, optimally from 10 to 30 micron.
The starch is commercially available under the tradename Tapioca Pure (28-1810) from 30 the National Starch & Chemical Company, Division of ICI. An alternative source is TIStar Tapioca Starch sold by the Multi-Kern Corporation.
Amounts of tapioca starch may range from 0.1 to 10%, preferably from 0.5 to 5%, optimally from 0.3 to 1 % by weight of the composition. 35

WO 2008/028900

PCT/EP200 7/059220

Advantageously the tapioca starch in certain formulations preferably is a water-insoluble partially hydrated granular substance having an average particle size ranging from 500 to 10,000 nm, preferably from 1,000 to 9,000 nm, optimally from 3,000 to 8,000 nm. Partially hydrated starches are achieved by heating tapioca starch in water to 50°C and 5 holding this temperature for from 0.5 to 4 hours, preferably from 1 to 2 hours. Partial hydration converts from 10 to 80% by weight of the tapioca starch to a hydrated form.
Ethylene brassylate is a second component of the present invention. This material is available from many sources including Takasago International Corporation. Amounts of 10 ethylene brassylate may range from 0.001 to 5%, preferably from 0.01 to 1%, and more preferably from 0.1 to 0.5% by weight of the composition.
Advantageously the relative weight amounts of ethylene brassylate to tapioca starch may respectively range from 1:200 to 5:1, preferably from 1:100 to 3:1, more preferably from 15 1:10 to 1:1, even more preferably from 1:3 to 1:1, optimally from 1:5 to 1:2 by weight of the composition.
Emulsifiers may also be present in cosmetic compositions of the present invention. Total concentration of the emulsifier when present may range from 0.01 to 10%, preferably
20 from 0.1 to 5%, optimally from 1 to 3% by weight of the composition. The emulsifier may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic emulsifiers are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C-10 alkyl phenols condensed with from 2 to 20 moles of
25 alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8~C2o fatty acids; and polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e,g. methyl gluconamides) are also suitable nonionic emulsifiers.
30 Polyhydric alcohols may be employed in certain compositions of the present invention. Typical polyhydric alcohols include glycerin (also known as glycerol), polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol,
35 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The

WO 2008/028900

PCT/EP2007/059220

amount of polyhydric alcohol when present may range from 0.1 to 40%, preferably from 0.5 to 20%, optimally from 1 to 10% by weight of the composition.
Preservatives can desirably be incorporated into the cosmetic compositions of this 5 invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Particularly preferred preservatives are phenoxyethanol, methyl paraben,
10 propyl paraben, DMDM hydantoin, iodopropynyl butylcarbamate, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazolin-3-one and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.00001% to 2% by
15 weight of the composition.
Preferred anionic surfactants include soap, C8-C20 alkyl ether sulfates and sulfonates, Cr C2o alkyl sulfates and sulfonates, C8-C20 alkylbenzene sulfonates, C8-C2o alkyl and dialkyl sulfosuccinates, C8-C2o acyl isethionate, C8-C2o alkyl ether phosphates, C8-C20 20 sarcosinates, C8-C2o acyl iactylates and combinations thereof.
Polysiloxane materials may be present in compositions of this invention. The organopolysiloxane may be volatile, non-volatile, or a mixture of volatile and non-volatile silicones. The term "non-volatile" refers to those silicones that are liquid or solid under 25 ambient conditions and have a flash point (under one atmosphere pressure) of at least about 100°C. The term "volatile" refers to all other silicone oils. Suitable organopolysiloxanes include polyalkylsiloxanes, cyclic polyalkylsiloxanes and polyalkylarylsiloxanes.
30 Polyalkylsiloxanes can be represented by the general chemical formula R3SiO[R2SiO]xSiR3 wherein R is an alkyl group having from one to about 30 carbon atoms (preferably R is methyl or ethyl) and x is an integer from 0 to about 10,000, chosen to achieve the desired molecular weight which can range to over about 10,000,000. Commercially available polyalkylsiloxanes include the poiydimethylsiloxanes, which are
35 also known as dimethicones. These include the Vicasil® series sold by General Electric Company and the Dow Corning® 200 series sold by Dow Corning Corporation.

WO 2008/028900

PCT/EP2007/059220

Dimethicones include those represented by the chemical formula (CH3)3SiO[(CH3)2SiO])([CH3RSiO]ySi(CH3)3 wherein R is straight or branched chain alkyl having from 2 to about 30 carbon atoms and x and y are each integers of 1 or greater selected to achieve the desired molecular weight which can range to over about 5 10,000,000. Examples of these alkylsubstituted dimethicones include cetyl dimethicone and lauryl dimethicone.
Cyclic polyalkylsiloxanes suitable for use in the composition include those represented by the chemical formula [SiR2-0]n wherein R is an alkyl group (preferably R is methyl or
10 ethyl) and n is an integer from about 3 to about 8, more preferably from 4 to 6. Where R is methyl, these materials are typically referred to as cyclomethicones. Commercially available cyclomethicones include Dow Corning® 244 fluid which primarily contains the cyclomethicone tetramer (i.e. n=4), Dow Corning® 344 fluid which primarily contains the cyclomethicone pentamer (i.e. n=5), Dow Corning® 245 which primarily contains a
15 mixture of the cyclomethicone tetramer and pentamer (i.e. n=4 and 5), and Dow Corning® 345 which primarily contains a mixture of the cyclomethicone tetramer, pentamer and hexamer (ie. n=4, 5 and 6).
Also useful are materials such as trimethylsiloxysilicate, which is a polymeric material 20 corresponding to the general chemical formula [(CH3)SiO)x(SiO2)y, wherein x is an integer from about 1 to about 500 and y is an integer from about 1 to about 500. A commercially available trimethylsiloxysilicate is sold as a mixture with dimethicone as Dow Corning® 593 fluid.
25 Dimethiconols are also suitable for use in the composition. These compounds can be represented by the chemical formulas R3SiO[R2SiO]xSiR2OH and HOR2SiO[R2SiO])(SiR20H wherein R is an alkyl group (preferably R is methyl or ethyl) and x is an integer from 0 to about 500, chosen to achieve the desired molecular weight. Commercially available dimethiconols are typically sold as mixtures with dimethicone or
30 cyclomethicone (e.g. Dow Corning® 1401, 1402, 1403 and 1501 fluids). Particularly preferred is a blend with INCl name of Cyclopentasiloxane and PEG/PPG-20/15 Dimethicone commercially available from GE Silicones as SF1528.
Cross-linked organopolysiloxane elastomers may also be useful as polysiloxane
35 materials. These may be of the emulsifying or non-emulsifying crosslinked elastomer
variety. The term "non-emulsifying" defines a crosslinked organopolysiloxane elastomer

WO 2008/028900

PCT/EP2007/059220

from which polyoxyalkylene units are absent. The term "emulsifying" is used to mean crosslinked organopolysiloxane elastomer having at least one polyoxyalkylene unit.
Non-emulsifying silicone elastomers may be powders such as vinyl 5 dimethicone/methicone silesquioxane crosspolymers available from Shin-Etsu as KSP-100, KSP-101, KSP-102, KSP-103, KSP-104 and KSP-105, hybrid silicone powders that contain a fluoroalkyl group such as KSP-200, and hybrid silicone powders that contain a phenyl group such as KSP-300; and Dow Corning material DC 9506.
10 Preferred organopolysiloxane compositions are dimethicone/vinyl dimethicone crosspolymers commercially available from Dow Corning (DC 9040 and DC 9045), General Electric (SFE 839), Shin Etsu (KSG-15, 16, 18 [dimethicone/phenyl vinyl dimethicone crosspolymer]), and Grant Industries (Gransil™ line of materials), and lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu (KSG-31, KSG-32,
15 KSG-41, KSG-42, KSG-43 and KSG-44).
Particularly useful emulsifying elastomers are polyoxyalkylene-modified elastomers formed from divinyl compounds, particularly siloxane polymers with at least two free vinyl groups, reacting with Si-H linkages on a polysiloxane backbone. Preferably, the 20 elastomers are dimethyl poiysiloxanes crosslinked by Si-H sites on a molecuiarly spherical MQ resin.
Combinations of emulsifying and non-emulsifying crosslinked siloxane elastomers may also be useful for purposes of this invention. 25
Amounts of the polysiloxane materials may range from 0.1 to 80%, preferably from 1 to 60%, optimally from 5 to 40% by weight of the composition.
Fatty acids having from 10 to 30 carbon atoms may in certain formulations also be 30 suitable for compositions of the present invention. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids. Particularly preferred is stearic acid. Amounts of the fatty acid may range from 0.1 to 20%, preferably from 0.5 to 10%, optimally from 1 to 5% by weight of the composition.

WO 2008/028900

PCT/EP2007/059220

Another component which may be utilized in compositions of the present invention is that of polyacrylic beads. Especially useful are polymethyl methacrylate, polyethyl methacrylate, polyethyl acrylate and polymethyl acrylate polymers. Most preferred are polymethyl methacrylate beads. The beads can range in number average particle size 5 from 1 to 50 micron, preferably from 3 to 30 micron, optimally from 5 to 10 micron. These beads may be cross-linked or non-cross-linked, but cross-linking is preferred. The beads may have an Oil Absorbance ranging from 60 to 300 ml/100g and preferably from 70 to 180 ml/100g, as defined by ASTM-D281-31. Beads of polymethyl methacrylate are sold under the trademark Ganzpearl, available from Presperse Incorporated (Piscataway, New 10 . Jersey 08854). Most preferred is Ganzpearl® GMP-0820 with number average particle size of about 8 micron and an Oil Absorbance of about 170 ml/1 OOg.
Amounts of the polyacrylate beads may range from 0.001 to 5%, preferably from 0.01 to 1%, optimally from 0.1 to 0.5% by weight of the composition.
15
Compositions of this invention will include a cosmetically acceptable carrier. Amounts of the carrier may range from 1 to 99.9%, preferably from 50 to 95%, optimally from 80 to 90%. Among the useful carriers are water, emollients, fatty alcohols, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion.
20 Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or O/W variety. Water when present may be in amounts ranging from 1 to 95%, preferably from 20 to 70%, optimally from 35 to 60% by weight.
Emollient materials may serve as cosmetically acceptable carriers. These may be in the 25 form of natural or synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from 0.1 to 95%, preferably between 1 and 50% by weight.
Among the ester emollients are:
a) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples
30 thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate,
isopropyl myristate, oleyl stearate and oleyl oleate.
b) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
c) Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene
glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-
35 fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene
glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated

WO 2008/028900

PCT/EP2007/059220

propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol
poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol
monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid
ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are
5 satisfactory polyhydric alcohol esters. Particularly useful are pentaerythritol,
trim ethyl ol propane and neopentyl glycol esters of C1-C30 alcohols.
d) Wax esters such as beeswax, spermaceti wax and tribehenin wax.
e) Sterols esters, of which cholesterol fatty acid esters are examples thereof.
f) Sugar esters of fatty acids such as sucrose polybehenate and sucrose 10 polycottonseedate.
g) Natural esters useful in this invention are sunflower seed oil, safflower oil,
cottonseed oil, olive oil, jojoba and mixtures thereof.
Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, 15 mineral oil, C11C13 isoparaffins, polyalphaolefins, and especially isohexadecane, available commercially as Permethyl 101Afrom Presperse Incorporated.
Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier. Illustrative are stearyl alcohol, lauryl alcohol, myristyl 20 alcohol and cetyl alcohol. Amounts may range from 0.05 to 20%, preferably from 0.1 to 2% by weight of the composition.
Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include polyacrylamides (e.g.
25 Sepigel 305®), acryioyldimethyitaurate polymers and copolymers (e.g. Aristoflex AVC), cross-linked acrylates (e.g. Carbopol 982®), hydrophobically-modified acrylates (e.g. Carbopol 1382®), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methocellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl
30 cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenum, pectin and combinations of these gums. Inorganics may also be utilized as thickeners, particularly clays such as bentonites and hectorites, fumed silicas, and silicates such as magnesium aluminum silicate (Veegum®). Amounts of the thickener may range from 0.0001 to 10%, usually from 0.001 to 1%, optimally from 0.01
35 to 0.5% by weight of the composition.

WO 2008/028900

PCT/EP2007/059220

Cosmetic compositions of the present invention may be in any form. These forms may include lotions, creams, roll-on formulations, sticks, masks, mousses, aerosol and non-aerosol sprays and pad-applied (e.g. wipe) formulations.
5 Sunscreen actives may also be included in compositions of the present invention. Particularly preferred are such materials as ethylhexyl p-methoxycinnamate (available as Parsol MCX®), Avobenzene (available as Parsol 1789®) and benzophenone-3 (also known as Oxybenzone). Inorganic sunscreen actives may be employed such as microfine titanium dioxide and zinc oxide. Amounts of the sunscreen agents when 10 present may generally range from 0.1 to 30%, preferably from 2 to 20%, optimally from 4 to 10% by weight.
Compositions of the present invention may also contain vitamins and their derivatives. By the term "derivatives" is meant C1-C40 alkyl esters, salts or isomers. The vitamins may
15 include vitamin A and derivatives (e.g. retinyl palmitate, retinyl linoleate, retinyl acetate and retinoic acid), vitamin B (including niacinamide, DL-panthenol, pyridoxine palmitate, folic acid, carotin and biotin), vitamin C (including magnesium ascorbyl phosphate, ascorbyl tetraisopalmitate and ascorbyl glucoside), vitamin D, vitamin E (including tocopherol palmitate, tocopherol acetate and the alpha-, beta- and gamma- isomers of
20 tocopherol) and combinations thereof. Total amount of vitamins when present in compositions according to the present invention may range from 0.00001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the composition.
Skin lightening agents may be included in the compositions of the invention. Illustrative 25 substances are placental extract, lactic acid, niacinamide, arbutin, kojic acid, resorcinot and derivatives including 4-substituted resorcinols and combinations thereof. Amounts of these agents may range from 0.1 to 10%, preferably from 0.5 to 2% by weight of the composition.
30 Desquamation agents are further optional components. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids. Among the former are salts of glycolic acid, lactic acid and malic acid. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from 0.01 to 15% by weight of the composition.
35

WO 2008/028900

PCT/EP2007/059220

A variety of herbal extracts may optionally be included in compositions of this invention. Illustrative are green tea, chamomile, licorice, lavender, grape seed and extract combinations thereof. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the 5 preferred extract solvents.
Flavonoids may also be included in compositions of this invention. The flavonoids may be selected from isoflavonoids, flavonols and combinations thereof. Particularly useful are glucosyl hesperidin and rutin. Amounts of these agents may range from 0.000001 to 10 5% by weight of the composition.
Anti-microbial agents may also be included in the compositions of this invention. Illustrative are trichlosan, trichlocarban, Octopyrox® and zinc pyrithione. Amounts may range from 0.01 to 5%, preferably from 0.1 to 0.5% by weight of the composition. 15
Colorants, fragrances, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from 0.05 to 5%, preferably between 0.1 and 3% by weight of the composition.
20 The term "comprising" is meant not to be limiting to any subsequentty stated elements but rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above.
25
It should be noted that in specifying any range of concentration or amount, any particular upper concentration can be associated with any particular lower concentration or amount.
The following examples will more fully illustrate the embodiments of this invention. All 30 parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.
EXAMPLES 1-8
Typical body lotions according to the present invention are illustrated in the examples of 35 table I.

o
TABLE I 1

EXAMPLE (WEIGHT %)
TRADEMARK CHEMICAL NAME 1 2 3 4 5 6 7 8
Pristerene 4911 Stearic acid 6.5 7.5 8.5 1.0 2.0 3.0 4.0 5.0
Ritasynt Glycerol monostearate/ Stearamide AMP 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5
Kessco GMS Glycerol monostearate 0.5 1.0 0.5 0.5 1.0 0.5 1.5 1.5
Cetyl Alcohol Cetyl alcohol 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
IPM Isopropyl myristate 7.5 5.0 5.0 5.0 5.0 7.5 10.0 5.0
Silicone Fluid 50 cts Dimethicone 4.0 5.0 6.0 2.0 2.0 4.0 4.0 8.0
Disodium EDTA Disodium EDTA 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05
Glycerin Glycerin 5.0 5.0 5.0 5.0 5.0 5.0 10.0 10.0
Veegum Magnesium aluminum silicate 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
KeltrolCG 100 Xanthan gum 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Carbopol 934 (2% Active) Carbomer 9.0 9.0 9.0 12.0 12.0 6.5 6.5 6.5
Titanium Dioxide Titanium dioxide 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Triethanofamine (99%) Triethanolamine 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
DC 245 Fluid Cyclopentasiloxane 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
DC 1501 Dimethiconol 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Ganzpearl GMP 0820 Methyl methacrylate crosspolymer 0.25 0.25 0.5 0.5 0.5 0.75 0.75 0.25
GE SF 1528 Dimethicone copolyol/ cyclomethicone 0.75 1.0 0.75 0.75 2.0 2.0 5.0 0.25
Tapioca Pure Tapioca starch 1.75 1.75 2.0 2.0 5.0 5.0 2.25 1.75
Glydant Plus lodopropynyl butylcarbamate/DMDM hydantoin 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09
Ethylene Brassylate Ethylene brassylate 0.1 0.5 1.0 2.0 1.0 1.5 0.8 0.3
Fragrance Fragrance 0.15 0 1.0 0.75 0.75 0.15 0.15 1.1
Water Balance Balance Balance Balance Balance Balance Balance Balance

WO 2008/028900

PCT/EP2007/059220

The formulations of table I are blended in the following manner. Above specified quantities of water, disodium EDTA, titanium dioxide and gum xanthan/glycerin slurry (2%) are charged to a batching vessel. These components are mixed for five minutes and then the Carborner is added as a solution. Heat is applied and the mixed contents 5 are held at 80°C for fifteen minutes. The remaining glycerin is added. The oil phase ingredients are then charged to a separate vessel. Light mixing is begun and heat applied to achieve 80°C. Slowly, the oil phase is added to the water phase under moderate mixing while maintaining temperature. All remaining water is charged to the vessel. Then the contents are homogenized at 80°C for one minute. Contents are then 10 cooled to 38-40°C accompanied by large sweep (75 rpm) mixing. Glydant Plus is added at 55°C. Cooling is continued accompanied by slow addition at no higher than 50°C of DC 1501, fragrance, ethylene brassylate and tapioca along with the various minor ingredients.
15 EXAMPLE 9
Illustrated herein is a skin cream according to the present invention.
TABLE II

INGREDIENT WEIGHT %
Glycerin 6.95
Niacinamide 5.00
Tapioca starch 5.00
Permethyl 101A1 3.00
Sepigel 305' 2.50
DC-1403* 2.00
1 so propyl isostearate 1.50
Arlatone212r 1.00
Cetyl alcohol 0.75
SEFA cottonate1' 0.70
Tocopherol acetate 0.50
Panthenol 0.50
Stearyl alcohol 0.50
Titanium dioxide 0.40
Ethylene brassylate 0.35
Disodium EDTA 0.10
Glydant Plus" 0.10
PEG-100stearate 0.10
Stearic acid 0.10
Purified water Balance
1 Isohexadecane (Presperse Inc., South Plainfield, NJ)
20 2 Polyacrylamide(and)C13-14 Isoparaffin(and) Laureth-7 (Seppic Corp, Fairfield, NJ)
3 Dimethicone(and)dimethtconol (Dow Corning Corp. Midland, Ml)
4 Sorbitan Monostearate and Sucrococoate (ICI Americas Inc., Wilmington, DE)
5 Sucrose ester of fatty acid
6 DMDM Hydantoin (and) lodopropynyl Butylcarbamate (Lonza Inc., Fairlawn, NJ)

WO 2008/028900

PCT/EP2007/059220

EXAMPLE 10
Another oil-in-water emulsion according to the present invention is described under table

5 TABLE lll

INGREDIENT WEIGHT %
Phase A
Distilled water balance
Phase B
Glycerin 5.00
Titanium dioxide . 0.75
Phase C
Glycerin 1.00
Disodium EDTA 0.10
Carbopol® 954 0.68
Carbopol®1382 0.10
Tapioca starch 2.50
Phase D
Cetyl alcohol 0.70
Stearyl alcohol 0.50
Stearic acid 0.10
PEG-100stearate 0.10
Glycerol monostearate 1.00
Dimethicone 2.00
Cyclomethicone 0.65
Tocopherol acetate 0.10
Niacinamide 2.00
Phase E
Distilled water 2.00
NaOH To neutralize
Phase F
Urea 2.00
D-Panthenol 0.10
Distilled water 5.00
Phase G
Glydant Plus 0.10
Glycerin 1.00
Distilled water 1.00
Phase H
Ethylene brassylate 1.00
Methyl isostearate 1.50
Ganzpeart® GMP 0820 0.50
Retinol 0.50
Butylated hydroxy toluene 0.05
Tween® 20 1.00

WO 2008/028900

PCT/EP2007/059220

EXAMPLE 11
A hand cream according to the present invention is herein reported under table IV.
TABLE IV

INGREDIENT WEIGHT %
Distearyldimonium chloride (VarisoftTAlOO®) 4.1
Cetyl alcohol 2.9
Steareth 21 1.7
Stearyl stearate 0.01
Petrolatum 0.3
Dimethicone 200/200 1.0
Mineral Oil 1000SUS 2.8
Isopropyl palmitate 4.0
Soy sterol 0.1
Stearic acid 0.1
Lecithin 0.1
Borage seed oil 0.1
Vitamin E acetate 0.1
Propylparaben 0.1
Sodium chloride 0.2
Glycerin 10.0
Titanium dioxide 0.1
Methyl paraben 0.2
Tapioca starch 0.5
DMDM hydantoin 0.3
Ethylene brassylate 0.2
Water Balance
EXAMPLE 12
Herein is reported a conditioning body butter with the formula outlined under table V.
TABLE V

INGREDIENT WEIGHT %
Stearic acid 2.5
Glycol stearate and stearamide AMP 1.5
Glyceryl monostearate 0.7
Cetyl alcohol 0.4
Dimethicone 2.5
Petrolatum 0.5
Ethylhexyicocoate & hydrogenated didecene 2.5
Cocoa Butter 1.3
Microcrystalline wax 0.3
Paraffin eax 0.3
Propylparaben 0.1
Disodium EDTA 0.1

WO 2008/028900 PCT7EP2007/059220

INGREDIENT WEIGHT %
Methyl para ben 0.2
PEG-90 diisostearate (Hydramal PGDS) 3.0
Viscolam AP64 (sodium acrylate/sodium acryloyldimethyl taurate copolymer, hydrogenated polydecene, Laureth-8) 1.5
Triethanolamine 0.8
Xanthan Gum 0.1
Glycerin 15.0
Cyclopentasiloxane (DC 245) 4.0
Tapioca 2.0
Cyclopentasiloxane and dimethiconol (DC1501) 0.5
Cyclopentasiloxane and dimethicone copolyol (SF1528) 0.5
Phenoxyethanol 0.4
Ethylene brassylate 0.2
Water Balance
EXAMPLE 13
Herein is reported a healing foot cream having a formula outlined under table VI.
5 TABLE VI

INGREDIENT WEIGHT %
Disodium EDTA 0.1
Magnesium aluminum silicate (Veegum Ultra) 0.3
Glycerin 3.0
Butylene glycol 2.0
Methyl paraben 0.2
Xanthan gum 0.2
Hydroxyethylcellulose (Natrosol) 0.1
Stearic acid 3.6
Glycol stearate and stearamide AMP 2.1
Glyceryl stearate 1.0
Cetyl alcohol 0.6
PEG-100 stearate 1.8
Petrolatum 12.0
Caprylic/capric triglyceride 1.8
Dimethicone (200cts) 1.0
Ethylhexyl methoxycinnamate 0.5
Sunflower seed oil 1.0
Propylparaben 0.1
Glydant (DMDM hydantoin) 0.3
Lactic acid and potassium lactate 8.0
Ethylene brassylate 0.6
Tapioca starch 3.5
Deionized water Balance

WO 2008/028900

PCT/EP2007/059220

EXAMPLE 14
Herein is reported a moisture locking lotion with the formula as recorded in table VII. In this formula the tapioca starch is added last to the oil and water phases at a temperature no higher than 40°C. This ensures that the tapioca starch becomes only partially 5 hydrated.
TABLE VII

INGREDIENT WEIGHT %
Oil Phase
Stearic acid 4.5
Glycol stearate and stearamide AMP 1.0
Glyceryl monostearate 0.7
Cetyl alcohol 0.4
Petrolatum 6.5
Dimethicone (200cts) 1.0
Isopropyl isostearate 1.0
Propylparaben 0.1

Water Phase
Dl water Balance
Disodium EDTA 0.1
Methylparaben 0.2
Glycerin USP 12.0
Titanium dioxide (water dispersible) 0.1
Magnesium aluminum silicate (Veegum) 0.2
Carbopol 934 2% solution 9.0
Triethanolamine 1.1

Cool Down Phase
Dl water 10.0
Tapioca starch 1.0
Phenoxyethanol 0.4
Ethylene brassylate 0.1
10 EXAMPLE 15
A series of experiments were conducted to evaluate skinfeel performance through instrumentation. Various combinations of tapioca starch and ethylene brassylate were evaluated for slip friction as a function of time. This procedure measures friction during the first ten minutes of drying after application. The test is conducted in an
15 environmentally controlled chamber at 2TC and 20% relative humidity. Sample size of 100 microliters is spread on a Lucite table over a 6 by 5 inch area (2.54 cm to the inch). The table is attached to the cross-head of an Instron Model 4501 Materials Testing

WO 2008/028900

PCT/EP2007/059220

System. A 3 by 1 inch aluminum sled covered with a 100% rayon non-woven is pulled across the same area at a rate of 10 cm/min, starting one minute after application and repeated each minute for ten minutes. The integral of force vs. a distance of 50 mm (i.e. amount of work, units of gram-mm) is calculated for each of the intervals. Three runs are 5 made of each product.
Table VIII identifies the amounts of tapioca and ethylene brassylate for each sample in a base formula similar to that of example 1 (water varied in accordance with levels of tapioca starch, ethylene brassylate and com starch). Slip friction results are reported in 10 table IX.
TABLE VIII

Sample Tapioca (weight %) Ethylene Brassylate (weight %) Com Starch (weight %)
A 0 2.0 0
B 0.5 1.5 0
C 2.0 0 0
D 1.0 1.0 0
E 1.5 0.5 0
F 0 1.0 1.0
15 TABLE IX

Sample Slip Work Load (gram-mm)
A 768.2
B 743.8
C 742.3
D 662.9
E 633.1
F 728.5
The results shown in table IX demonstrate that a combination of ethylene brassylate and tapioca starch (samples D and E) provide better slip results (lower friction) than either of 20 the separate materials (samples A and C). Further, the results of ethylene brassylate with tapioca are much better than the ethylene brassylate combination with corn starch. Compare sample C to sample F.

WO 2008/028900

PCT/EP2007/059220

While particular embodiments of the subject invention have been described it will be obvious to those skilled in the art that various changes and modifications to the subject invention can be made without departing from the spirit and scope of the invention. It is intended to cover, in the appended claims, all such modifications that are within the scope 5 of the subject invention.



CLAIMS
1. A cosmetic composition comprising:
(i) from 0.1 to 10% by weight of tapioca starch;
5 (II) from 0.001 to 5% by weight of ethylene brassyiate;
(Hi) from 0.01 to 10% by weight of an emulsifies
(iv) optionally, an effective amount to provide an initial silky fee! upon skin
contact of a polysiloxane material;
(v) optionally, from 0.1 to 40% by weight of polyhydric alcohol;
10 (vi) optionally, an effective amount to preserve of a preservative; and
(vi't) a cosmetically acceptable carrier.
2. A cosmetic composition according to claim 1, wherein the tapreca starch is
present in an amount from 0.5 to 5% by weight of the composition.
15 '
3. A cosmetic composition according to claim 1, wherein ethylene brassylate is
present in an amount from 0.1 to 0.5% by weight of the composition.
4, A composition according to claim 1, wherein ethylene brassylate and tnpieca
20 otaruh are person a rolaiivo amount ranging from 1:200 to 5:1.
- A oocmotio GornpooUion according to oloim 1, whcroin othyfrnr; bressy ETE inrl
Japlochot and piosont in a folativo woight ratio from 1;10 to 1:1.

25 . A cosmetic composition according to claim 1, wherein the tapioca starch is a partially hydrolyzed material.
S
A cosmetic composition according to claim 1, wherein the polyhydric alcohol is
glycerin.
30
A cosmetic composition according to claim 1, wherein the polysiloxane material is
present from 0.1 to 80% by weight of the composition.

Documents:

0412-MUMNP-2009 CORRESPONDENCE (14-9-2009).pdf

0412-MUMNP-2009 POWER OF ATTORNEY (14-9-2009).pdf

412-MUMNP-2009-ANNEXURE TO FORM 3(22-6-2012).pdf

412-MUMNP-2009-CLAIMS(26-2-2009).pdf

412-MUMNP-2009-CLAIMS(AMENDED)-(3-9-2012).pdf

412-MUMNP-2009-CLAIMS(MARKED COPY)-(3-9-2012).pdf

412-MUMNP-2009-CORRESPONDENCE(21-5-2010).pdf

412-MUMNP-2009-DESCRIPTION(COMPLETE)-(26-2-2009).pdf

412-MUMNP-2009-EP DOCUMENT(22-6-2012).pdf

412-MUMNP-2009-FORM 13(9-2-2012).pdf

412-MUMNP-2009-FORM 18(21-5-2010).pdf

412-MUMNP-2009-FORM 2(COMPLETE)-(26-2-2009).pdf

412-MUMNP-2009-FORM 2(TITLE PAGE)-(26-2-2009).pdf

412-MUMNP-2009-FORM 3(12-08-2011).pdf

412-MUMNP-2009-FORM 3(15-2-2011).pdf

412-MUMNP-2009-FORM 3(15-2-2012).pdf

412-MUMNP-2009-FORM 3(24-2-2010).pdf

412-MUMNP-2009-FORM 3(4-8-2010).pdf

412-MUMNP-2009-FORM 3(8-8-2012).pdf

412-MUMNP-2009-REPLY TO EXAMINATION REPORT(22-6-2012).pdf

412-MUMNP-2009-REPLY TO EXAMINATION REPORT(3-9-2012).pdf

412-MUMNP-2009-US DOCUMENT(22-6-2012).pdf

412mumnp2009- assignment.pdf

412mumnp2009- pct-ipea-409.pdf

412mumnp2009- pct-ipea-416.pdf

412mumnp2009- pct-isa-210.pdf

412mumnp2009-certificate.pdf

412mumnp2009-claims.doc

412mumnp2009-claims.pdf

412mumnp2009-correspondence.pdf

412mumnp2009-description(complete).doc

412mumnp2009-description(complete).pdf

412mumnp2009-form 1.pdf

412mumnp2009-form 2(title page).pdf

412mumnp2009-form 2.doc

412mumnp2009-form 2.pdf

412mumnp2009-form 3.pdf

412mumnp2009-form 5.pdf

412mumnp2009-general power of attorney.pdf

412mumnp2009-wo international publication report a1.pdf


Patent Number 254683
Indian Patent Application Number 412/MUMNP/2009
PG Journal Number 49/2012
Publication Date 07-Dec-2012
Grant Date 05-Dec-2012
Date of Filing 26-Feb-2009
Name of Patentee HINDUSTAN UNILEVER LIMITED
Applicant Address UNILEVER HOUSE, B.D. SAWANT MARG, CHAKALA, ANDHERI EAST, MUMBAI-400 099 MAHARASHTRA, INDIA
Inventors:
# Inventor's Name Inventor's Address
1 OLSEN AMY LYNN 201C WINDGATE CIRCLE, MONROE, CONNECTICUT 06468,
2 MINER PHILIP EDWARD UNILEVER HOME & PERSONAL CARE USA, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611,
PCT International Classification Number A61K 8/49
PCT International Application Number PCT/EP2007/059220
PCT International Filing date 2007-09-04
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 11/470635 2006-09-07 U.S.A.